ID   MBL2_HUMAN              Reviewed;         248 AA.
AC   P11226; Q4VB12; Q4VB13; Q4VB14; Q5SQS3; Q86SI4; Q96KE4; Q96TF7; Q96TF8;
AC   Q96TF9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   03-AUG-2022, entry version 236.
DE   RecName: Full=Mannose-binding protein C {ECO:0000305};
DE            Short=MBP-C;
DE   AltName: Full=Collectin-1;
DE   AltName: Full=MBP1;
DE   AltName: Full=Mannan-binding protein;
DE   AltName: Full=Mannose-binding lectin;
DE   Flags: Precursor;
GN   Name=MBL2 {ECO:0000312|HGNC:HGNC:6922}; Synonyms=COLEC1, MBL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2450948; DOI=10.1084/jem.167.3.1034;
RA   Ezekowitz R.A.B., Day L.E., Herman G.A.;
RT   "A human mannose-binding protein is an acute-phase reactant that shares
RT   sequence homology with other vertebrate lectins.";
RL   J. Exp. Med. 167:1034-1046(1988).
RN   [2]
RP   ERRATUM OF PUBMED:2450948.
RA   Ezekowitz R.A.B., Day L.E., Herman G.A.;
RL   J. Exp. Med. 174:753-753(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SEQUENCE REVISION.
RC   TISSUE=Liver;
RX   PubMed=2477486; DOI=10.1084/jem.170.4.1175;
RA   Sastry K., Herman G.A., Day L.E., Deignan E., Bruns G., Morton C.C.,
RA   Ezekowitz R.A.B.;
RT   "The human mannose-binding protein gene. Exon structure reveals its
RT   evolutionary relationship to a human pulmonary surfactant gene and
RT   localization to chromosome 10.";
RL   J. Exp. Med. 170:1175-1189(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2590164; DOI=10.1042/bj2620763;
RA   Taylor M.E., Brickell P.M., Craig R.K., Summerfield J.A.;
RT   "Structure and evolutionary origin of the gene encoding a human serum
RT   mannose-binding protein.";
RL   Biochem. J. 262:763-771(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-52; ASP-54 AND GLU-57.
RX   PubMed=9743385;
RA   Madsen H.O., Satz M.L., Hogh B., Svejgaard A., Garred P.;
RT   "Different molecular events result in low protein levels of mannan-binding
RT   lectin in populations from South-East Africa and South America.";
RL   J. Immunol. 161:3169-3175(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-24.
RC   TISSUE=Liver;
RA   Chen Z., Zhu X., Xie P.;
RT   "Cloning and sequencing of mannan-binding lectin cDNA of Chinese.";
RL   Mian Yi Xue Za Zhi 15:83-86(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wu Z., Zhang S., Wang Y.;
RT   "Prokaryotic expression of human mbl.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tan J., Ong R., Hibberd M.L., Seielstad M.;
RT   "Genetic variation in immune response genes.";
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Lai Q., Zuo D., Chen Z.;
RT   "Cloning and sequencing of mannan-binding lectin gene from chinese Han
RT   people.";
RL   Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-54.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-59, AND VARIANT ASP-54.
RX   PubMed=12175909; DOI=10.1016/s0027-5107(02)00142-2;
RA   Jueliger S., Kremsner P.G., Alpers M.P., Reeder J.C., Kun J.F.J.;
RT   "Restricted polymorphisms of the mannose-binding lectin gene in a
RT   population of Papua New Guinea.";
RL   Mutat. Res. 505:87-91(2002).
RN   [13]
RP   PROTEIN SEQUENCE OF 21-248, SUBCELLULAR LOCATION, AND HYDROXYLATION AT
RP   PRO-47; PRO-73; PRO-79; PRO-82 AND PRO-88.
RC   TISSUE=Liver, and Plasma;
RX   PubMed=7982896; DOI=10.1093/oxfordjournals.jbchem.a124471;
RA   Kurata H., Sannoh T., Kozutsumi Y., Yokota Y., Kawasaki T.;
RT   "Structure and function of mannan-binding proteins isolated from human
RT   liver and serum.";
RL   J. Biochem. 115:1148-1154(1994).
RN   [14]
RP   INTERACTION WITH MASP1 AND MASP2.
RX   PubMed=9087411; DOI=10.1038/386506a0;
RA   Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W.J., Laursen S.B.,
RA   Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B.M.,
RA   Jensenius J.C.;
RT   "A second serine protease associated with mannan-binding lectin that
RT   activates complement.";
RL   Nature 386:506-510(1997).
RN   [15]
RP   FUNCTION.
RX   PubMed=14515269; DOI=10.1002/eji.200323888;
RA   Nauta A.J., Raaschou-Jensen N., Roos A., Daha M.R., Madsen H.O.,
RA   Borrias-Essers M.C., Ryder L.P., Koch C., Garred P.;
RT   "Mannose-binding lectin engagement with late apoptotic and necrotic
RT   cells.";
RL   Eur. J. Immunol. 33:2853-2863(2003).
RN   [16]
RP   DNA-BINDING.
RX   PubMed=15145932; DOI=10.1074/jbc.m403763200;
RA   Palaniyar N., Nadesalingam J., Clark H., Shih M.J., Dodds A.W.,
RA   Reid K.B.M.;
RT   "Nucleic acid is a novel ligand for innate, immune pattern recognition
RT   collectins surfactant proteins A and D and mannose-binding lectin.";
RL   J. Biol. Chem. 279:32728-32736(2004).
RN   [17]
RP   INTERACTION WITH MEP1A AND MEP1B.
RX   PubMed=16116208; DOI=10.4049/jimmunol.175.5.3177;
RA   Hirano M., Ma B.Y., Kawasaki N., Okimura K., Baba M., Nakagawa T., Miwa K.,
RA   Kawasaki N., Oka S., Kawasaki T.;
RT   "Mannan-binding protein blocks the activation of metalloproteases meprin
RT   alpha and beta.";
RL   J. Immunol. 175:3177-3185(2005).
RN   [18]
RP   TISSUE SPECIFICITY.
RX   PubMed=18006063; DOI=10.1016/j.molimm.2007.10.006;
RA   Hummelshoej T., Fog L.M., Madsen H.O., Sim R.B., Garred P.;
RT   "Comparative study of the human ficolins reveals unique features of
RT   Ficolin-3 (Hakata antigen).";
RL   Mol. Immunol. 45:1623-1632(2008).
RN   [19]
RP   INTERACTION WITH CR1.
RX   PubMed=23460739; DOI=10.4049/jimmunol.1202451;
RA   Jacquet M., Lacroix M., Ancelet S., Gout E., Gaboriaud C., Thielens N.M.,
RA   Rossi V.;
RT   "Deciphering complement receptor type 1 interactions with recognition
RT   proteins of the lectin complement pathway.";
RL   J. Immunol. 190:3721-3731(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   INTERACTION WITH CR1.
RX   PubMed=29563915; DOI=10.3389/fimmu.2018.00453;
RA   Jacquet M., Cioci G., Fouet G., Bally I., Thielens N.M., Gaboriaud C.,
RA   Rossi V.;
RT   "C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on
RT   CCP24-25 Modules.";
RL   Front. Immunol. 9:453-453(2018).
RN   [22]
RP   INTERACTION WITH SARS-COV-2 SPIKE GLYCOPROTEIN (MICROBIAL FUNCTION),
RP   FUNCTION, AND POLYMORPHISM.
RX   PubMed=35102342; DOI=10.1038/s41590-021-01114-w;
RA   Stravalaci M., Pagani I., Paraboschi E.M., Pedotti M., Doni A.,
RA   Scavello F., Mapelli S.N., Sironi M., Perucchini C., Varani L.,
RA   Matkovic M., Cavalli A., Cesana D., Gallina P., Pedemonte N., Capurro V.,
RA   Clementi N., Mancini N., Invernizzi P., Bayarri-Olmos R., Garred P.,
RA   Rappuoli R., Duga S., Bottazzi B., Uguccioni M., Asselta R., Vicenzi E.,
RA   Mantovani A., Garlanda C.;
RT   "Recognition and inhibition of SARS-CoV-2 by humoral innate immunity
RT   pattern recognition molecules.";
RL   Nat. Immunol. 23:275-286(2022).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 108-248, SUBUNIT, AND COILED-COIL.
RX   PubMed=7634089; DOI=10.1038/nsb1194-789;
RA   Sheriff S., Chang C.Y., Ezekowitz R.A.;
RT   "Human mannose-binding protein carbohydrate recognition domain trimerizes
RT   through a triple alpha-helical coiled-coil.";
RL   Nat. Struct. Biol. 1:789-794(1994).
RN   [24]
RP   VARIANT ASP-54, AND ASSOCIATION WITH MANNOSE-BINDING PROTEIN DEFICIENCY AND
RP   SUSCEPTIBILITY TO CHRONIC INFECTIONS.
RX   PubMed=1675710; DOI=10.1016/0140-6736(91)93263-9;
RA   Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W.,
RA   Summerfield J.A.;
RT   "Molecular basis of opsonic defect in immunodeficient children.";
RL   Lancet 337:1569-1570(1991).
RN   [25]
RP   VARIANTS ASP-54 AND GLU-57, AND ASSOCIATION WITH MANNOSE-BINDING PROTEIN
RP   DEFICIENCY.
RX   PubMed=1304173; DOI=10.1093/hmg/1.9.709;
RA   Lipscombe R.J., Sumiya M., Hill A.V.S., Lau Y.L., Levinsky R.J.,
RA   Summerfield J.A., Turner M.W.;
RT   "High frequencies in African and non-African populations of independent
RT   mutations in the mannose binding protein gene.";
RL   Hum. Mol. Genet. 1:709-715(1992).
RN   [26]
RP   ERRATUM OF PUBMED:1304173.
RA   Lipscombe R.J., Sumiya M., Hill A.V.S., Lau Y.L., Levinsky R.J.,
RA   Summerfield J.A., Turner M.W.;
RL   Hum. Mol. Genet. 2:342-342(1993).
RN   [27]
RP   VARIANT ASP-54.
RX   PubMed=1303250; DOI=10.1038/ng0992-50;
RA   Super M., Gillies S.D., Foley S., Sastry K., Schweinle J.E.,
RA   Silverman V.J., Ezekowitz R.A.;
RT   "Distinct and overlapping functions of allelic forms of human mannose
RT   binding protein.";
RL   Nat. Genet. 2:50-55(1992).
RN   [28]
RP   VARIANTS CYS-52; ASP-54 AND GLU-57.
RX   PubMed=10447262;
RX   DOI=10.1002/(sici)1098-1004(1999)14:1<80::aid-humu10>3.0.co;2-j;
RA   Gabolde M., Muralitharan S., Besmond C.;
RT   "Genotyping of the three major allelic variants of the human mannose-
RT   binding lectin gene by denaturing gradient gel electrophoresis.";
RL   Hum. Mutat. 14:80-83(1999).
RN   [29]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO HBV INFECTION, AND VARIANTS CYS-52; ASP-54
RP   AND GLU-57.
RX   PubMed=15994813; DOI=10.1128/jvi.79.14.9192-9196.2005;
RA   Thio C.L., Mosbruger T., Astemborski J., Greer S., Kirk G.D., O'Brien S.J.,
RA   Thomas D.L.;
RT   "Mannose binding lectin genotypes influence recovery from hepatitis B virus
RT   infection.";
RL   J. Virol. 79:9192-9196(2005).
RN   [30]
RP   VARIANT GLU-57, AND ASSOCIATION WITH PROTECTION AGAINST TUBERCULOSIS.
RX   PubMed=21695215; DOI=10.1371/journal.pone.0020908;
RA   Thye T., Niemann S., Walter K., Homolka S., Intemann C.D., Chinbuah M.A.,
RA   Enimil A., Gyapong J., Osei I., Owusu-Dabo E., Rusch-Gerdes S.,
RA   Horstmann R.D., Ehlers S., Meyer C.G.;
RT   "Variant G57E of mannose binding lectin associated with protection against
RT   tuberculosis caused by Mycobacterium africanum but not by M.
RT   tuberculosis.";
RL   PLoS ONE 6:E20908-E20908(2011).
CC   -!- FUNCTION: Calcium-dependent lectin involved in innate immune defense
CC       (PubMed:35102342). Binds mannose, fucose and N-acetylglucosamine on
CC       different microorganisms and activates the lectin complement pathway.
CC       Binds to late apoptotic cells, as well as to apoptotic blebs and to
CC       necrotic cells, but not to early apoptotic cells, facilitating their
CC       uptake by macrophages. May bind DNA. Upon SARS coronavirus-2/SARS-CoV-2
CC       infection, activates the complement lectin pathway which leads to the
CC       inhibition SARS-CoV-2 infection and a reduction of the induced
CC       inflammatory response (PubMed:35102342). {ECO:0000269|PubMed:14515269,
CC       ECO:0000269|PubMed:35102342}.
CC   -!- SUBUNIT: Oligomeric complex of 3 or more homotrimers. Interacts with
CC       MASP1 and MASP2. Interacts with MEP1A and MEP1B and may inhibit their
CC       catalytic activity. Interacts with CR1 (via Sushi 24 and Sushi 25
CC       domains). {ECO:0000269|PubMed:16116208, ECO:0000269|PubMed:23460739,
CC       ECO:0000269|PubMed:29563915, ECO:0000269|PubMed:7634089,
CC       ECO:0000269|PubMed:9087411}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SARS coronavirus-2/SARS-
CC       CoV-2 Spike glycoprotein homotrimer; the interaction is calcium-
CC       dependent and modulated by Spike glycoprotein glycosylation state.
CC       {ECO:0000269|PubMed:35102342}.
CC   -!- INTERACTION:
CC       P11226; P02743: APCS; NbExp=2; IntAct=EBI-5325353, EBI-2115799;
CC       P11226; P02749: APOH; NbExp=3; IntAct=EBI-5325353, EBI-2114682;
CC       P11226; P27797: CALR; NbExp=6; IntAct=EBI-5325353, EBI-1049597;
CC       P11226; P17927: CR1; NbExp=8; IntAct=EBI-5325353, EBI-2807625;
CC       P11226; Q9UGM3: DMBT1; NbExp=2; IntAct=EBI-5325353, EBI-1044970;
CC       P11226; Q07954: LRP1; NbExp=5; IntAct=EBI-5325353, EBI-1046087;
CC       P11226; P48740-1: MASP1; NbExp=9; IntAct=EBI-5325353, EBI-16138717;
CC       P11226; P48740-2: MASP1; NbExp=8; IntAct=EBI-5325353, EBI-26435098;
CC       P11226; P48740-3: MASP1; NbExp=7; IntAct=EBI-5325353, EBI-26435118;
CC       P11226; PRO_0000027592 [P48740]: MASP1; NbExp=2; IntAct=EBI-5325353, EBI-26356151;
CC       P11226; O00187: MASP2; NbExp=6; IntAct=EBI-5325353, EBI-7965040;
CC       P11226; O00187-2: MASP2; NbExp=3; IntAct=EBI-5325353, EBI-26356134;
CC       P11226; PRO_0000027598 [O00187]: MASP2; NbExp=2; IntAct=EBI-5325353, EBI-25426044;
CC       P11226; P11226: MBL2; NbExp=6; IntAct=EBI-5325353, EBI-5325353;
CC       P11226; P10124: SRGN; NbExp=4; IntAct=EBI-5325353, EBI-744915;
CC       P11226; O00206: TLR4; NbExp=2; IntAct=EBI-5325353, EBI-528701;
CC       P11226; Q9UHD9: UBQLN2; NbExp=5; IntAct=EBI-5325353, EBI-947187;
CC       P11226; PRO_0000037570 [P27958]; Xeno; NbExp=6; IntAct=EBI-5325353, EBI-6904269;
CC       PRO_0000017401; PRO_0000000214 [P9WQP3]: fbpA; Xeno; NbExp=2; IntAct=EBI-25427940, EBI-26878164;
CC       PRO_0000017401; P9WQP1: fbpB; Xeno; NbExp=2; IntAct=EBI-25427940, EBI-26878221;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:7982896}.
CC   -!- TISSUE SPECIFICITY: Plasma protein produced mainly in the liver.
CC       {ECO:0000269|PubMed:18006063}.
CC   -!- DOMAIN: The coiled-coil domain mediates trimerization.
CC   -!- POLYMORPHISM: Genetic variations in MBL2 influence susceptibility to
CC       hepatitis B virus (HBV) infection [MIM:610424].
CC       {ECO:0000269|PubMed:15994813}.
CC   -!- POLYMORPHISM: Genetic variations in MBL2 may influence susceptibility
CC       to severe COVID-19 disease caused by SARS-CoV-2 virus infection.
CC       {ECO:0000269|PubMed:35102342}.
CC   -!- POLYMORPHISM: Genetic variations in MBL2 are responsible for mannose-
CC       binding protein deficiency [MIM:614372]. This condition is defined as
CC       MBL2 protein level of less than 100 ng/ml, is present in about 5% of
CC       people of European descent and in about 10% of sub-Saharan Africans.
CC       Most MBL2-deficient adults appear healthy, but low levels of MBL2 are
CC       associated with increased risk of infection in toddlers, in cancer
CC       patients undergoing chemotherapy, and in organ-transplant patients
CC       receiving immunosuppressive drugs, particularly recipients of liver
CC       transplants. There is an association between low levels of MBL2 and a
CC       defect of opsonization which results in susceptibility to frequent and
CC       chronic infections (PubMed:1675710). Functional MBL2 deficiency may be
CC       associated with protection against tuberculosis caused by Mycobacterium
CC       africanum but not by Mycobacterium tuberculosis, as observed in studies
CC       on Ghanaian patients with pulmonary tuberculosis (PubMed:21695215).
CC       {ECO:0000269|PubMed:1675710, ECO:0000269|PubMed:21695215}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Mannose-binding protein;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_227";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15422; CAA33462.1; -; mRNA.
DR   EMBL; X15954; CAA34079.1; -; Genomic_DNA.
DR   EMBL; X15955; CAA34079.1; JOINED; Genomic_DNA.
DR   EMBL; X15956; CAA34079.1; JOINED; Genomic_DNA.
DR   EMBL; X15957; CAA34079.1; JOINED; Genomic_DNA.
DR   EMBL; AF080510; AAC31937.1; -; Genomic_DNA.
DR   EMBL; AF080508; AAC31937.1; JOINED; Genomic_DNA.
DR   EMBL; AF080509; AAC31937.1; JOINED; Genomic_DNA.
DR   EMBL; Y16576; CAB56044.1; -; Genomic_DNA.
DR   EMBL; Y16577; CAB56120.1; -; Genomic_DNA.
DR   EMBL; Y16578; CAB56045.1; -; Genomic_DNA.
DR   EMBL; Y16579; CAB56121.1; -; Genomic_DNA.
DR   EMBL; Y16580; CAB56122.1; -; Genomic_DNA.
DR   EMBL; Y16581; CAB56123.1; -; Genomic_DNA.
DR   EMBL; Y16582; CAB56124.1; -; Genomic_DNA.
DR   EMBL; AF360991; AAK52907.1; -; mRNA.
DR   EMBL; AY826184; AAV80468.1; -; mRNA.
DR   EMBL; DQ217939; ABB01009.1; -; Genomic_DNA.
DR   EMBL; EU596574; ACC62880.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54148.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54149.1; -; Genomic_DNA.
DR   EMBL; BC096179; AAH96179.1; -; mRNA.
DR   EMBL; BC096180; AAH96180.3; -; mRNA.
DR   EMBL; BC069338; AAH69338.1; -; mRNA.
DR   EMBL; BC096181; AAH96181.3; -; mRNA.
DR   EMBL; BC096182; AAH96182.3; -; mRNA.
DR   EMBL; AF482699; AAN39274.1; -; Genomic_DNA.
DR   EMBL; AF482700; AAN39275.1; -; Genomic_DNA.
DR   CCDS; CCDS7247.1; -.
DR   PIR; JL0115; LNHUMC.
DR   RefSeq; NP_000233.1; NM_000242.2.
DR   RefSeq; XP_006717924.1; XM_006717861.3.
DR   RefSeq; XP_011538118.1; XM_011539816.2.
DR   PDB; 1HUP; X-ray; 2.50 A; A=108-248.
DR   PDBsum; 1HUP; -.
DR   AlphaFoldDB; P11226; -.
DR   SMR; P11226; -.
DR   BioGRID; 110323; 33.
DR   ComplexPortal; CPX-6170; MBL2-MASP1 lectin-protease complex.
DR   ComplexPortal; CPX-6203; MBL2-MASP2 lectin-protease complex.
DR   DIP; DIP-61381N; -.
DR   IntAct; P11226; 26.
DR   MINT; P11226; -.
DR   STRING; 9606.ENSP00000363079; -.
DR   ChEMBL; CHEMBL1795113; -.
DR   DrugBank; DB02837; 4-(Hydrogen sulfate)-beta-D-galactopyranose.
DR   DrugBank; DB03879; alpha-L-methyl-fucose.
DR   DrugBank; DB04426; Alpha-Methyl-N-Acetyl-D-Glucosamine.
DR   DrugBank; DB01979; Methyl alpha-D-mannoside.
DR   DrugBank; DB03194; Methyl beta-L-fucopyranoside.
DR   DrugBank; DB03721; N-acetyl-alpha-neuraminic acid.
DR   DrugBank; DB01818; O3-Sulfonylgalactose.
DR   UniLectin; P11226; -.
DR   iPTMnet; P11226; -.
DR   PhosphoSitePlus; P11226; -.
DR   BioMuta; MBL2; -.
DR   DMDM; 126676; -.
DR   CPTAC; non-CPTAC-2684; -.
DR   jPOST; P11226; -.
DR   MassIVE; P11226; -.
DR   PaxDb; P11226; -.
DR   PeptideAtlas; P11226; -.
DR   PRIDE; P11226; -.
DR   ProteomicsDB; 52723; -.
DR   TopDownProteomics; P11226; -.
DR   Antibodypedia; 693; 759 antibodies from 40 providers.
DR   DNASU; 4153; -.
DR   Ensembl; ENST00000373968.3; ENSP00000363079.3; ENSG00000165471.7.
DR   Ensembl; ENST00000674931.1; ENSP00000502789.1; ENSG00000165471.7.
DR   Ensembl; ENST00000675947.1; ENSP00000502615.1; ENSG00000165471.7.
DR   GeneID; 4153; -.
DR   KEGG; hsa:4153; -.
DR   MANE-Select; ENST00000674931.1; ENSP00000502789.1; NM_001378373.1; NP_001365302.1.
DR   UCSC; uc001jjt.3; human.
DR   CTD; 4153; -.
DR   DisGeNET; 4153; -.
DR   GeneCards; MBL2; -.
DR   HGNC; HGNC:6922; MBL2.
DR   HPA; ENSG00000165471; Tissue enriched (liver).
DR   MalaCards; MBL2; -.
DR   MIM; 154545; gene.
DR   MIM; 610424; phenotype.
DR   MIM; 614372; phenotype.
DR   neXtProt; NX_P11226; -.
DR   OpenTargets; ENSG00000165471; -.
DR   Orphanet; 449306; Antibiotic therapy dose selection.
DR   PharmGKB; PA30665; -.
DR   VEuPathDB; HostDB:ENSG00000165471; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000154368; -.
DR   HOGENOM; CLU_049894_3_0_1; -.
DR   InParanoid; P11226; -.
DR   OMA; CAKFQAS; -.
DR   OrthoDB; 1222552at2759; -.
DR   PhylomeDB; P11226; -.
DR   TreeFam; TF330481; -.
DR   PathwayCommons; P11226; -.
DR   Reactome; R-HSA-166662; Lectin pathway of complement activation.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; P11226; -.
DR   SIGNOR; P11226; -.
DR   BioGRID-ORCS; 4153; 8 hits in 1070 CRISPR screens.
DR   EvolutionaryTrace; P11226; -.
DR   GeneWiki; Mannan-binding_lectin; -.
DR   GenomeRNAi; 4153; -.
DR   Pharos; P11226; Tbio.
DR   PRO; PR:P11226; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P11226; protein.
DR   Bgee; ENSG00000165471; Expressed in right lobe of liver and 15 other tissues.
DR   Genevisible; P11226; HS.
DR   GO; GO:0009986; C:cell surface; TAS:BHF-UCL.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; IC:ComplexPortal.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; IPI:ComplexPortal.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005537; F:mannose binding; IDA:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0006953; P:acute-phase response; TAS:BHF-UCL.
DR   GO; GO:0140374; P:antiviral innate immune response; IDA:UniProtKB.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001867; P:complement activation, lectin pathway; IDA:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; TAS:BHF-UCL.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:MGI.
DR   GO; GO:0045087; P:innate immune response; IDA:BHF-UCL.
DR   GO; GO:0051873; P:killing by host of symbiont cells; IEA:Ensembl.
DR   GO; GO:0048525; P:negative regulation of viral process; IDA:BHF-UCL.
DR   GO; GO:0008228; P:opsonization; TAS:BHF-UCL.
DR   GO; GO:1903028; P:positive regulation of opsonization; IDA:ComplexPortal.
DR   GO; GO:0006508; P:proteolysis; IDA:ComplexPortal.
DR   GO; GO:0006979; P:response to oxidative stress; NAS:UniProtKB.
DR   CDD; cd03591; CLECT_collectin_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR033990; Collectin_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR037570; Mannose-binding_protein_C.
DR   PANTHER; PTHR24024:SF34; PTHR24024:SF34; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Coiled coil; Collagen;
KW   Complement activation lectin pathway; Complement pathway;
KW   Direct protein sequencing; Disulfide bond; Hydroxylation; Immunity;
KW   Innate immunity; Lectin; Mannose-binding; Reference proteome; Repeat;
KW   Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   CHAIN           21..248
FT                   /note="Mannose-binding protein C"
FT                   /id="PRO_0000017401"
FT   DOMAIN          42..99
FT                   /note="Collagen-like"
FT   DOMAIN          134..245
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          43..113
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          112..130
FT                   /evidence="ECO:0000269|PubMed:7634089"
FT   MOD_RES         47
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   MOD_RES         73
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   MOD_RES         79
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   MOD_RES         82
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   MOD_RES         88
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7982896"
FT   DISULFID        155..244
FT   DISULFID        222..236
FT   VARIANT         24
FT                   /note="T -> A (in Chinese)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_013294"
FT   VARIANT         52
FT                   /note="R -> C (in 0.05% of European and African
FT                   populations; dbSNP:rs5030737)"
FT                   /evidence="ECO:0000269|PubMed:10447262,
FT                   ECO:0000269|PubMed:15994813, ECO:0000269|PubMed:9743385"
FT                   /id="VAR_008543"
FT   VARIANT         54
FT                   /note="G -> D (associated with low serum mannose-binding
FT                   protein (MBP) concentrations and recurrent infections;
FT                   dbSNP:rs1800450)"
FT                   /evidence="ECO:0000269|PubMed:10447262,
FT                   ECO:0000269|PubMed:12175909, ECO:0000269|PubMed:1303250,
FT                   ECO:0000269|PubMed:1304173, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:15994813, ECO:0000269|PubMed:1675710,
FT                   ECO:0000269|PubMed:9743385"
FT                   /id="VAR_004182"
FT   VARIANT         57
FT                   /note="G -> E (associated with low serum mannose-binding
FT                   protein (MBP) concentrations; associated with protection
FT                   against tuberculosis caused by Mycobacterium africanum;
FT                   dbSNP:rs1800451)"
FT                   /evidence="ECO:0000269|PubMed:10447262,
FT                   ECO:0000269|PubMed:1304173, ECO:0000269|PubMed:15994813,
FT                   ECO:0000269|PubMed:21695215, ECO:0000269|PubMed:9743385"
FT                   /id="VAR_004183"
FT   VARIANT         214
FT                   /note="N -> Y (in dbSNP:rs12260094)"
FT                   /id="VAR_050119"
FT   HELIX           110..129
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          131..134
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          137..147
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   HELIX           148..157
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   HELIX           168..177
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          182..187
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          222..225
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:1HUP"
FT   STRAND          238..247
FT                   /evidence="ECO:0007829|PDB:1HUP"
SQ   SEQUENCE   248 AA;  26144 MW;  C1F2AAED46D0F774 CRC64;
     MSLFPSLPLL LLSMVAASYS ETVTCEDAQK TCPAVIACSS PGINGFPGKD GRDGTKGEKG
     EPGQGLRGLQ GPPGKLGPPG NPGPSGSPGP KGQKGDPGKS PDGDSSLAAS ERKALQTEMA
     RIKKWLTFSL GKQVGNKFFL TNGEIMTFEK VKALCVKFQA SVATPRNAAE NGAIQNLIKE
     EAFLGITDEK TEGQFVDLTG NRLTYTNWNE GEPNNAGSDE DCVLLLKNGQ WNDVPCSTSH
     LAVCEFPI
//
